背景介紹：

CultureBoost? Growth Factor (2x5mL）

規(guī)格：2x5mL 

說明：

使用我們的單批次培養(yǎng)基與試劑，獲得一致性

CultureBoost?是Cell Systems完全培養(yǎng)基（4Z0-500）和Cell Systems無血清培養(yǎng)基（4Z3-500）中的廣譜絲裂原。該產(chǎn)品含Cell Systems牛生長因子和豬肝素。每支5毫升CultureBoost?可補(bǔ)充一瓶500毫升培養(yǎng)基。

本品經(jīng)純化自牛垂體或下丘腦組織，原料可100%追溯至美國農(nóng)業(yè)部檢驗(yàn)設(shè)施加工的牛源。本品工作濃度為50μg/mL。經(jīng)CSC 2V0人靜脈內(nèi)皮細(xì)胞、ACBRI 181原代視網(wǎng)膜微血管內(nèi)皮細(xì)胞及ACBRI 376原代腦微血管內(nèi)皮細(xì)胞驗(yàn)證，其生物活性可調(diào)節(jié)至最大值的110%。

CultureBoost? 適用于 Cell Systems 培養(yǎng)基，可用于所有間充質(zhì)來源細(xì)胞的初始培養(yǎng)、解凍、擴(kuò)增及傳代操作。

使用CultureBoost?可使凍傷恢復(fù)率提高多達(dá)25%，每代細(xì)胞數(shù)增加10-20%，并使細(xì)胞匯合時間縮短一天。對于極度挑剔的細(xì)胞，CultureBoost?的效果最為顯著。

規(guī)格：

5毫升瓶裝規(guī)格包含于多種Cell Systems培養(yǎng)基試劑盒及“The System?”系統(tǒng)中。CultuBoost? 2×5毫升瓶裝規(guī)格亦可在此單獨(dú)購買。

儲存與處理

本產(chǎn)品在室溫下配送。每10毫升可補(bǔ)充500毫升細(xì)胞培養(yǎng)基。若30天內(nèi)無法用完全部產(chǎn)品，請分裝后冷凍保存。開封后在+2-8°C條件下保質(zhì)期為30天。

Cell Systems培養(yǎng)基和試劑均采用藥用級注射水（WFI）制備，所有組分均符合現(xiàn)行藥品生產(chǎn)質(zhì)量管理規(guī)范（cGMP）及ISO標(biāo)準(zhǔn)，并被歸類為“無菌”產(chǎn)品。

"Improvement in diabetic retinopathy through protection against retinal apoptosis in spontaneously diabetic Torii rats mediated by ethanol extract of Osteomeles schwerinae C.K. Schneid" Kim, Kim, Kim, et al. Nutrients, 2019.

"SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells" Nicolau et al American J Translational Research, 2018

"Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development" Beharry et al. Prostaglandins and Other Lipid Mediators, 2018

"Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid" Busatto and Vilanilam et al. Cells, 2018.

"Barrier properties and transcriptome expression in human iPSC‐derived models of the blood–brain barrier" Delsing et al. Stem Cells, 2018.

"MnTBAP or catalase Is more protective against oxidative stress in human retinal endothelial cells exposed to Intermittent hypoxia than their co-administration" Quan et al. Reactive Oxygen Species, 2017

"Association of HMGB1 with oxidative stress markers and regulators in PDR" Abu El-Asrar and Alam et al. Molecular Vision, 2017.

"Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells" Wang et al. Journal of Cell Science, 2016.

"Fenofibrate Inhibits cytochrome P450 epoxygenase 2C activity to suppress pathological ocular angiogenesis" Gong et al. EBioMedicine, 2016.

"Primary human liver co-culture With flow and Kupffer cell integration on microfluidic liver-on-a-chip" Mazur (Dissertation thesis), 2015.

"Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines" Momeny et al. Oncotarget, 2015.

"Aflibercept traps galectin-1, an angiogenic factor associated with diabetic retinopathy" Kanda et al. Scientific Reports, 2015.

"Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells" Liu et al. PLoS One, 2014.

"S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis" Abu El-Asrar et al. Molecular Vision, 2014.

"Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells" Safi et al. BMC Medical Genomics, 2014.

"Optical recording reveals novel properties of GSK1016790A-induced vanilloid transient receptor potential channel TRPV4 activity in primary human endothelial cells" Sullivan et al. Molecular Pharmacology, 2012.

"High-glucose-induced endothelial cell injury is inhibited by a peptide derived from human Apolipoprotein E" Bhattacharjee et al. PLoS One, 2012.

4CB-500

SDS